Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
LY2157299
Cat No.
CEI-0310
Description
LY2157299 can TGF-beta receptor I with IC50 of 56 nM.
CAS No.
700874-72-2
Molecular Weight
369.42
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
TGF-beta receptor I
Molecular Formula
C22H19N5O
Chemical Name
4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide
Solubility
DMSO 74 mg/mL Water
In vitro
LY2157299 is a new type I receptor TGF-beta kinase inhibitor. LY-2157299 could inhibit TGF-beta-mediated SMAD2 activation and hematopoietic suppression in primary hematopoietic stem cells. In vivo administration of LY-2157299 ameliorated anemia in a TGF-beta overexpressing transgenic mouse model of bone marrow failure. Treatment with LY-2157199 stimulated hematopoiesis from primay MDS bone marrow specimens.
Download
Download Datasheet